According to GlobalData’s medical device pipeline database, 95 Vagus Nerve Stimulators (VNS) devices are in various stages of development globally. GlobalData’s report Vagus Nerve Stimulators (VNS) provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 71 are in active development, while the remaining 26 are in an inactive stage of development. There are 28 products in the early stages of development, and the remaining 43 are in the late stages of development.
A VNS is a device comprised of an electrical pacemaker that sends electrical stimulation through surgically implanted electrodes to target the vagus nerve. VNSs are utilized to treat neurological disorders such as epilepsy and depression. One unit refers to one vagus nerve stimulator.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Vagus Nerve Stimulators (VNS) pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Vagus Nerve Stimulators (VNS) devices. Overall, most of these Vagus Nerve Stimulators (VNS) pipeline devices are being developed by private entities.
Key players involved in the active development of Vagus Nerve Stimulators (VNS) include ElectroCore, LivaNova, Feinstein Institute for Medical Research, Synergia Medical, Xana Stim, MicroTransponder, Bionics Institute, Cala Health, Neo-Bionica and Neurive.
For a complete picture of the developmental pipeline for Vagus Nerve Stimulators (VNS) devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.